HIV-1 Glycoprotein Immunogenicity

doi 10.5772/23209
Full Text
Abstract

Available in full text

Date
Authors
Publisher

InTech

Related search

Structure of the Transmembrane Domain of HIV-1 Envelope Glycoprotein

FEBS Journal
BiochemistryCell BiologyMolecular Biology
2016English

Immunogenicity of Varicella Zoster Virus Glycoprotein E DNA Vaccine

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2016English

Phase I Safety and Immunogenicity Evaluations of an Alphavirus Replicon HIV-1 Subtype C Gag Vaccine in Healthy HIV-1-Uninfected Adults

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2012English

Antibodies to the Primary Immunodominant Domain of Human Immunodeficiency Virus Type 1 (HIV-1) Glycoprotein Gp41 Enhance HIV-1 Infection in Vitro.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1990English

Safety and Immunogenicity of a Glycoprotein E Gene-Deleted Bovine Herpesvirus 1 Strain as a Candidate Vaccine Strain

Pesquisa Veterinaria Brasileira
Veterinary
2016English

Enhanced Immunogenicity of HIV-1 Vaccine Construct by Modification of the Native Peptide Sequence

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1997English

Safety and Immunogenicity of a Gag-Pol Candidate HIV-1 DNA Vaccine Administered by a Needle-Free Device in HIV-1-Seronegative Subjects

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2007English

Apoptosis and Karyogamy in Syncytia Induced by the HIV-1-envelope Glycoprotein Complex

Cell Death and Differentiation
Cell BiologyMolecular Biology
2000English

HIV-1 Integrase Inhibitors Are Substrates for the Multidrug Transporter MDR1-P-glycoprotein

Retrovirology
VirologyInfectious Diseases
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy